In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

EuroHeart Project Development



Pilot Phase 1: July 2019 – June 2022

During this phase, the project team communicated with over twenty countries, resulting in nine countries participating in EuroHeart: Estonia, Hungary, Portugal, Romania, Denmark, Sweden, Lithuania, Iceland and Singapore. 

During the Pilot Phase, EuroHeart data standards for four disease domains were developed: ACS-PCI, heart failure, atrial fibrillation, and TAVI; The EuroHeart Registry IT platform was developed and implemented in three countries: Estonia, Romania and Lithuania (in progress). More information on the Pilot Phase.

Consolidation Phase: July 2022 - June 2024

Pending a positive evaluation of the Pilot Phase, the EuroHeart project will transition into a two-year Consolidation Phase. This phase aims to expand the EuroHeart network to at least sixteen countries, develop four additional data standards and establish the EuroHeart Data Science Centre to enable processes for collaborative research projects. The project will also develop the EuroHeart Registry IT platform to support registry-based randomised clinical trials (R-RCT) and device/drug surveillance research. More information on the Consolidation Phase to be followed.